Moreover, previous studies indicated that the use of immune checkpoint inhibitors increases the risk of drug-induced pneumonitis if various tyrosine kinase inhibitors such as EGFR-TKIs were previously administered (16). The gene discussed is EGFR; the disease is pneumonitis.